| Ident. | Authors (with country if any) | Title |
|---|
| 000019 |
Ishrat Sultana [États-Unis] ; Kevin Yang [États-Unis] ; Melkamu Getie-Kebtie [États-Unis] ; Laura Couzens [États-Unis] ; Lewis Markoff [États-Unis] ; Michail Alterman [États-Unis] ; Maryna C. Eichelberger [États-Unis] | Stability of neuraminidase in inactivated influenza vaccines |
| 000142 |
Susanne Röhrs [Allemagne] ; Donata Kalthoff [Allemagne] ; Martin Beer [Allemagne] | A model for early onset of protection against lethal challenge with highly pathogenic H5N1 influenza virus |
| 000144 |
LAN HUANG [République populaire de Chine] ; YANG CAO [République populaire de Chine] ; JIANFANG ZHOU [République populaire de Chine] ; KUN QIN [République populaire de Chine] ; WENFEI ZHU [République populaire de Chine] ; YUN ZHU [République populaire de Chine] ; LEI YANG [République populaire de Chine] ; DAYAN WANG [République populaire de Chine] ; HONG WEI [République populaire de Chine] ; YUELONG SHU [République populaire de Chine] | A Conformational Restriction in the Influenza A Virus Neuraminidase Binding Site by R152 Results in a Combinational Effect of I222T and H274Y on Oseltamivir Resistance |
| 000234 |
PEICHEN PAN [République populaire de Chine] ; LIN LI [République populaire de Chine] ; YOUYONG LI [République populaire de Chine] ; DAN LI [République populaire de Chine] ; TINGJUN HOU [République populaire de Chine] | Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations |
| 000252 |
Stella G. Muthuri [Royaume-Uni] ; Puja R. Myles [Royaume-Uni] ; Sudhir Venkatesan [Royaume-Uni] ; Jo Leonardi-Bee [Royaume-Uni] ; Jonathan S. Nguyen-Van-Tam [Royaume-Uni] | Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients |
| 000281 |
William Murtaugh [États-Unis] ; Lalla Mahaman [États-Unis] ; Benjamin Healey [États-Unis] ; Heather Peters [États-Unis] ; Barbara Anderson [États-Unis] ; Mandy Tran [États-Unis] ; Marci Ziese [États-Unis] ; Maria Paz Carlos [États-Unis] | Evaluation of Three Influenza Neuraminidase Inhibition Assays for Use in a Public Health Laboratory Setting During the 2011-2012 Influenza Season |
| 000331 |
Robert B. Couch [États-Unis] ; Robert L. Atmar [États-Unis] ; Luis M. Franco [États-Unis] ; John M. Quarles [États-Unis] ; Janet Wells [États-Unis] ; Nancy Arden [États-Unis] ; Diane Nino [États-Unis] ; John W. Belmont [États-Unis] | Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase |
| 000376 |
TRONG TUAN DAO [Corée du Sud] ; THAI TRUNG DANG [Corée du Sud] ; PHI HUNG NGUYEN [Corée du Sud] ; Eunhee Kim [Corée du Sud] ; PHUONG THIEN THUONG [Namibie] ; WON KEUN OH [Corée du Sud] | Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses |
| 000416 |
WAI LAN WU [Hong Kong] ; Siu-Ying Lau [Hong Kong] ; YIXIN CHEN [République populaire de Chine] ; GENYAN WANG [République populaire de Chine] ; Bobo Wing-Yee Mok [Hong Kong] ; XI WEN [Hong Kong] ; PUI WANG [Hong Kong] ; WENJUN SONG [Hong Kong] ; TIANWEI LIN [République populaire de Chine] ; Kwok-Hung Chan [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] ; HONGLIN CHEN [Hong Kong, République populaire de Chine] | The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses |
| 000464 |
M. Redlberger-Fritz [Autriche] ; S. W. Aberle [Autriche] ; R. Strassl [Autriche] ; T. Popow-Kraupp [Autriche] | Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis |
| 000518 |
Futoshi Iioka [Japon] ; Ryuichi Sada [Japon] ; Yoshitomo Maesako [Japon] ; Fumihiko Nakamura [Japon] ; Hitoshi Ohno [Japon] | Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation |
| 000533 |
Katja Bauer [Allemagne] ; Ralf Dürrwald [Allemagne] ; Michael Schlegel [Allemagne] ; Kathrin Pfarr [Allemagne] ; Dominik Topf Nadine Wiesener [Allemagne] ; Hans-Martin Dahse [Allemagne] ; Peter Wutzler [Allemagne] ; Michaela Schmidtke [Allemagne] | Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008 |
| 000587 |
Jennifer L. Mckimm-Breschkin [Australie] ; Christina Rootes [Australie] ; Peter G. Mohr [Australie] ; Susan Barrett [Australie] ; Victor A. Streltsov [Australie] | In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir |
| 000593 |
Andres Pizzorno [Canada] ; Yacine Abed [Canada] ; Xavier Bouhy [Canada] ; Edith Beaulieu [Canada] ; Corey Mallett [Canada] ; Rupert Russell [Royaume-Uni] ; Guy Boivin [Canada] | Impact of Mutations at Residue 1223 of the Neuraminidase Protein on the Resistance Profile, Replication Level, and Virulence of the 2009 Pandemic Influenza Virus |
| 000620 |
Olivier Ferraris [France] ; Vanessa Escuret [France] ; Maude Bouscambert [France] ; Jean-Sébastien Casalegno [France] ; Frederic Jacquot [France] ; Herve Raoul [France] ; Valérie Caro [France] ; Martine Valette [France] ; Bruno Lina [France] ; Michele Ottmann [France] | H1N1 influenza A virus neuraminidase modulates infectivity in mice |
| 000682 |
Tohru Miyoshi-Akiyama [Japon] ; Yuki Akasaka [Japon] ; Teruko Oogane [Japon] ; Yuji Kondo [Japon] ; Takeji Matsushita [Japon] ; Keiji Funatogawa [Japon] ; Teruo Kirikae [Japon] | Development and evaluation of a line probe assay for rapid typing of influenza viruses and detection of the H274Y mutation |
| 000740 |
S. Tsiodras [Grèce] ; G. Nikolopoulos [Grèce] ; S. Bonovas [Grèce] | Antivirals Used for Influenza Chemoprophylaxis : Prophylactic Treatment with Antiviral Agents ro Prevent Infection and Disease |
| 000742 |
Nongluk Sriwilaijaroen [Thaïlande, Japon] ; Syuichi Fukumoto [Japon] ; Kenji Kumagai [Japon] ; Hiroaki Hiramatsu [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Yasuo Suzuki [Japon] | Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1 N1 viruses: Its role in viral hemagglutination and neuraminidase inhibition |
| 000744 |
Ha T. Nguyen [États-Unis] ; Alma A. Trujillo [États-Unis] ; Tiffany G. Sheu [États-Unis] ; Marnie Levine [États-Unis] ; Vasiliy P. Mishin [États-Unis] ; Michael Shaw [États-Unis] ; Edwin W. Ades [États-Unis] ; Alexander I. Klimov [États-Unis] ; Alicia M. Fry [États-Unis] ; Larisa V. Gubareva [États-Unis] | Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States |
| 000833 |
Norio Sugaya [Japon] ; Masayoshi Shinjoh [Japon] ; Keiko Mitamura [Japon] ; Takao Takahashi [Japon] | Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children |
| 000910 |
Eun-Sun Yoo [Corée du Sud] | Study of Specific Oligosaccharide Structures Related with Swine Flu (H1N1) and Avian Flu, and Tamiflu as Their Remedy |
| 000955 |
HANG XIE [États-Unis] ; XING LI [États-Unis] ; JIN GAO [États-Unis] ; ZHENGSHI LIN [États-Unis] ; XIANGHONG JING [États-Unis] ; Ewan Plant [États-Unis] ; Olga Zoueva [États-Unis] ; Maryna C. Eichelberger [États-Unis] ; ZHIPING YE [États-Unis] | Revisiting the 1976 "Swine Flu" Vaccine Clinical Trials: Cross-reactive Hemagglutinin and Neuraminidase Antibodies and Their Role in Protection Against the 2009 H1N1 Pandemic Virus in Mice |
| 000956 |
Jian R. Bao [États-Unis] ; Thomas K. Huard [États-Unis] ; Arelis E. Piscitelli [États-Unis] ; Praveena R. Tummala [États-Unis] ; Virginia E. Aleemi [États-Unis] ; Stephanie L. Coon [États-Unis] ; Ronald N. Master [États-Unis] ; Michael A. Lewinski [États-Unis] ; Richard B. Clark [États-Unis] | Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory |
| 000984 |
Frank R. Jones [États-Unis] ; Elizabeth S. Gabitzsch [États-Unis] ; YOUNONG XU [États-Unis] ; Joseph P. Balint [États-Unis] ; Viktoriya Borisevich [États-Unis] ; Jennifer Smith [États-Unis] ; Jeanon Smith [États-Unis] ; Bi-Hung Peng [États-Unis] ; Aida Walker [États-Unis] ; Magda Salazar [États-Unis] ; Slobodan Paessler [États-Unis] | Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine |
| 000A22 |
Daniel W. Brookes [Royaume-Uni] ; Shahajahan Miah [Royaume-Uni] ; Angie Lackenby [Royaume-Uni] ; Lorian Hartgroves [Royaume-Uni] ; Wendy S. Barclay [Royaume-Uni] | Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness |
| 000A40 |
Juan Ledesma [Espagne] ; Diego Vicente [Espagne] ; Francisco Pozo [Espagne] ; Gustavo Cilla [Espagne] ; Sonia Perez Castro [Espagne] ; Jonathan Suarez Fernandez [Espagne] ; Mercedes Perez Ruiz [Espagne] ; José Maria Navarro [Espagne] ; Juan Carlos Galan [Espagne] ; Mirian Fernandez [Espagne] ; Jordi Reina [Espagne] ; Amparo Larrauri [Espagne] ; Maria Teresa Cuevas [Espagne] ; Inmaculada Casas [Espagne] ; Pilar Perez Brena [Espagne] | Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain |
| 000A59 |
Jean Longtin [Canada] ; Samir Patell [Canada] ; Alireza Eshaghi [Canada] ; Ernesto Lombos [Canada] ; Rachel Higgins [Canada] ; David Alexander [Canada] ; Romy Olsha [Canada] ; John Doyle [Canada] ; Dat Tran [Canada] ; Alicia Sarabia [Canada] ; Christine Lee [Canada] ; Nathalie Bastien [Canada] ; YAN LI [Canada] ; Donald Low [Canada] ; Guy Boivin [Canada] ; Jonathan Gubbay [Canada] | Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada |
| 000B05 |
Ishrat Sultana [États-Unis] ; JIN GAO [États-Unis] ; Lewis Markoff [États-Unis] ; Maryna C. Eichelberger [États-Unis] | Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir |
| 000B83 |
Andrés Pizzorno [Canada] ; Xavier Bouhy [Canada] ; Yacine Abed [Canada] ; Guy Boivin [Canada] | Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors |
| 000D05 |
Shailendra K. Gupta [Inde, Allemagne] ; Shishir K. Gupta [Inde] ; Suchi Smita [Inde] ; Mugdha Srivastava [Inde] ; XIN LAI [Allemagne] ; Ulf Schmitz [Allemagne] ; Qamar Rahman [Inde] ; Olaf Wolkenhauer [Allemagne] ; Julio Vera [Allemagne] | Computational analysis and modeling the effectiveness of 'Zanamivir' targeting neuraminidase protein in pandemic H1N1 strains |
| 000D06 |
Thanyada Rungrotmongkol [Thaïlande] ; Pathumwadee Yotmanee [Thaïlande] ; Nadtanet Nunthaboot [Thaïlande] ; Supot Hannongbua [Thaïlande] | Computational Studies of Influenza A Virus at Three Important Targets: Hemagglutinin, Neuraminidase and M2 Protein |
| 000D42 |
TRONG TUAN DAO [Corée du Sud] ; PHI HUNG NGUYEN [Corée du Sud] ; HONG SIK LEE [Corée du Sud] ; Eunhee Kim [Corée du Sud] ; Junsoo Park [Corée du Sud] ; SEONG IL LIM [Corée du Sud] ; WON KEUN OH [Corée du Sud] | Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflate |
| 000E04 |
David Varillas [Espagne] ; Jesus F. Bermejo-Martin [Espagne] ; Raquel Almansa [Espagne] ; Silvia Rojo [Espagne] ; Bego A Nogueira [Espagne] ; Jose María Eiros [Espagne] ; Lucia Rico [Espagne] ; Ver Nica Iglesias [Espagne] ; Raul Ortiz De Lejarazu [Espagne] | A new method for detection of pandemic influenza virus using High Resolution Melting analysis of the neuraminidase gene |
| 000E11 |
Yi-Mo Deng [Australie] ; Natalie Caldwell [Australie] ; Aeron Hurt [Australie] ; Tim Shaw [Australie] ; Anne Kelso [Australie] ; Glenys Chidlow [Australie] ; Simon Williams [Australie] ; David Smith [Australie] ; Ian Barr [Australie] | A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1 ) 2009 viruses |
| 000F72 |
Andrés Anton [Espagne] ; Ana Alicia Lopez-Iglesias [Espagne] ; Teresa Tortola [Espagne] ; Isabel Ruiz-Camps [Espagne] ; Pau Abrisqueta [Espagne] ; Lluis Llopart [Espagne] ; María Angeles Marcos [Espagne] ; Miguel Julian Martinez [Espagne] ; Griselda Tudo [Espagne] ; Francesc Bosch [Espagne] ; Albert Pahissa [Espagne] ; Maria Teresa Jimenez De Anta [Espagne] ; Tomàs Pumarola [Espagne] | Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors |
| 001016 |
Musa Hindiyeh [Israël] ; Daniela Ram [Israël] ; Michal Mandelboim [Israël] ; Tal Meningher [Israël] ; Shira Hirsh [Israël] ; Jana Robinov [Israël] ; Virginia Levy [Israël] ; Sara Orzitzer [Israël] ; Roberto Azar [Israël] ; Zehava Grossman [Israël] ; Ella Mendelson [Israël] | Rapid Detection of Influenza A Pandemic (H1N1) 2009 Virus Neuraminidase Resistance Mutation H275Y by Real-Time Reverse Transcriptase PCR |
| 001109 |
Joshua M. Dinapoli [États-Unis] ; Baibaswata Nayak [États-Unis] ; LIJUAN YANG [États-Unis] ; Brad W. Finneyfrock [États-Unis] ; Anthony Cook [États-Unis] ; Hanne Andersen [États-Unis] ; Fernando Torres-Velez [États-Unis] ; Brian R. Murphy [États-Unis] ; Siba K. Samal [États-Unis] ; Peter L. Collins [États-Unis] ; Alexander Bukreyev [États-Unis] | Newcastle Disease Virus-Vectored Vaccines Expressing the Hemagglutinin or Neuraminidase Protein of H5N1 Highly Pathogenic Avian Influenza Virus Protect against Virus Challenge in Monkeys |
| 001126 |
NAZANIN ZAHRA SHAFIEI JANDAGHI [Iran] ; TALAT MOKHTARI AZAD [Iran] ; Maryam Naseri [Iran] ; Jila Yavarian [Iran] ; Rakhshandeh Nategh [Iran] | Molecular and genetic characteristics of hemagglutinin and neuraminidase in Iranian 2009 pandemic influenza A(H1N1) viruses |
| 001170 |
Glendie Marcelin [États-Unis] ; Hilliary M. Bland [États-Unis] ; Nicholas J. Negovetich [États-Unis] ; Matthew R. Sandbulte [États-Unis] ; Ali H. Ellebedy [États-Unis] ; Ashley D. Webb [États-Unis] ; Yolanda S. Griffin [États-Unis] ; Jennifer L. Debeauchamp [États-Unis] ; Janet E. Mcelhaney [États-Unis, Canada] ; Richard J. Webby [États-Unis] | Inactivated Seasonal Influenza Vaccines Increase Serum Antibodies to the Neuraminidase of Pandemic Influenza A(H1N1) 2009 Virus in an Age-Dependent Manner |
| 001185 |
Nathalie Bastien [Canada] ; Nick A. Antonishyn [Canada] ; Ken Brandt [Canada] ; Christine E. Wong [Canada] ; Khami Chokani [Canada] ; Niki Vegh [Canada] ; Greg B. Horsman [Canada] ; Shaun Tyler [Canada] ; Morag R. Graham [Canada] ; Frank A. Plummer [Canada] ; Paul N. Levett [Canada] ; YAN LI [Canada] | Human Infection with a Triple-Reassortant Swine Influenza A(H1N1) Virus Containing the Hemagglutinin and Neuraminidase Genes of Seasonal Influenza Virus |
| 001234 |
E. Van Der Vries [Pays-Bas] ; M. Jonges [Pays-Bas] ; S. Herfst [Pays-Bas] ; J. Maaskant [Pays-Bas] ; A. Van Der Linden [Pays-Bas] ; J. Guldemeester [Pays-Bas] ; G. I. Aron [Pays-Bas] ; T. M. Bestebroer [Pays-Bas] ; M. Koopmans [Pays-Bas] ; A. Meijer [Pays-Bas] ; R. A. M. Fouchier [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas] ; C. A. Boucher [Pays-Bas] ; M. Schutten [Pays-Bas] | Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1 ) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase |
| 001244 |
SHAKHINUR ISLAM MONDAL [Bangladesh] ; Abdullah Zubaer [Bangladesh] ; Simrika Thapa [Bangladesh] ; Chinmoy Saha [Bangladesh] ; Md. Asraful Alum [Bangladesh] ; Md. Salman Reza [Bangladesh] ; Arzuba Akter [Bangladesh] ; Abul Kalam Azad [Bangladesh, Japon] | Envelope Proteins Pertain with Evolution and Adaptive Mechanism of the Novel Influenza A/H1N1 in Humans |
| 001260 |
Ji-Rong Yang [Taïwan] ; Yuan-Pin Huang [Taïwan] ; Yu-Cheng Lin [Taïwan] ; Chun-Hui Su [Taïwan] ; Chuan-Yi Kuo [Taïwan] ; Li-Ching Hsu [Taïwan] ; Ho-Sheng Wu [Taïwan] ; Ming-Tsan Liu [Taïwan] | Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan |
| 001282 |
Rory Gunson [Royaume-Uni] ; Alasdair Maclean [Royaume-Uni] ; Eleri Davies [Royaume-Uni] ; Susan Bennett [Royaume-Uni] ; Rhona Miller [Royaume-Uni] ; W. F. Carman [Royaume-Uni] | Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus |
| 001289 |
BIN WANG [Australie] ; Dominic E. Dwyer [Australie] ; Christopher C. Blyth [Australie] ; Maly Soedjono [Australie] ; HAIJING SHI [Australie] ; Alison Kesson [Australie] ; Mala Ratnamohan [Australie] ; Ken Mcphie [Australie] ; Anthony L. Cunningham [Australie] ; Nitin K. Saksena [Australie] | Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections |
| 001460 |
Aeron C. Hurt [Australie] ; Jessica K. Holien [Australie] ; Michael Parker [Australie] ; Anne Kelso [Australie] ; Ian G. Barr [Australie] | Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation |
| 001584 |
Aeron C. Hurt [Australie] ; Jessica K. Holien [Australie] ; Michael W. Parker [Australie] ; Ian G. Barr [Australie] | Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses |
| 001586 |
Joan E. Adamo [États-Unis] ; Teresa Liu [États-Unis] ; Falko Schmeisser [États-Unis] ; ZHIPING YE [États-Unis] | Optimizing Viral Protein Yield of Influenza Virus Strain A/Vietnam/1203/2004 by Modification of the Neuraminidase Gene |
| 001598 |
Lain Stephenson [Royaume-Uni] ; Jane Democratis [Royaume-Uni] ; Angie Lackenby [Royaume-Uni] ; Teresa Mcnally [Royaume-Uni] ; James Smith [Suisse] ; Manish Pareek [Royaume-Uni] ; Joanna Ellis [Royaume-Uni] ; Alison Bermingham [Royaume-Uni] ; Karl Nicholson [Royaume-Uni] ; Maria Zambon [Royaume-Uni] ; Arnold S. Monto [États-Unis] | Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children. Commentary |
| 001660 |
S. M. Burns [Royaume-Uni] | H1N1 influenza is here |
| 001750 |
Mark Von Itzstein [Australie] ; Robin Thomson [Australie] | Anti-Influenza Drugs : The Development of Sialidase Inhibitors |
| 001916 |
HONG ZHANG [États-Unis] | Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza |
| 001929 |
Nadia Naffakh [France] ; Marie-Anne Rameix-Welti [France] ; Sylvie Van Der Werf [France] | CHIMIOTHÉRAPIES ANTI-INFLUENZA |
| 001941 |
Ompreya Suptawiwat [Thaïlande] ; Alita Kongchanagul [Thaïlande] ; Wisoot Chan-It [Thaïlande] ; Arunee Thitithanyanont [Thaïlande] ; Witawat Wiriyarat [Thaïlande] ; Krisada Chaichuen [Thaïlande] ; Taweesak Songserm [Thaïlande] ; Yasuo Suzuki [Japon] ; Pilaipan Puthavathana [Thaïlande] ; Prasert Auewarakul [Thaïlande] | A simple screening assay for receptor switching of avian influenza viruses |
| 001A49 |
Insung Ahn [Corée du Sud] ; Hyeon S. Son [Corée du Sud] | Comparative study of the hemagglutinin and neuraminidase genes of influenza A virus H3N2, H9N2, and H5N1 subtypes using bioinformatics techniques |
| 001B44 |
Gabriele A. Landolt [États-Unis] ; Alexander I. Karasin [États-Unis] ; Melissa M. Schutten [États-Unis] ; Christopher W. Olsen [États-Unis] | Restricted infectivity of a human-lineage H3N2 influenza A virus in pigs is hemagglutinin and neuraminidase gene dependent |
| 001C11 |
D. J. Alexander [Royaume-Uni] | Avian influenza viruses and human health |
| 001C26 |
Justin R. Ortiz [États-Unis] ; David K. Shay [États-Unis] ; Laura A. Liedtke [États-Unis] ; Joseph S. Bresee [États-Unis] ; Larry J. Strausbaugh [États-Unis] | A national survey of the infectious diseases society of america emerging infections network concerning neuraminidase inhibitor prescription practices and pandemic influenza preparations |
| 001C70 |
Takashi Suzuki [Japon] ; Tadanobu Takahashi [Japon] ; Chao-Tan Guo [Japon, République populaire de Chine] ; Kazuya I.-P. Jwa Hidari [Japon] ; Daisei Miyamoto [Japon] ; Hideo Goto [Japon] ; Yoshihiro Kawaoka [Japon, États-Unis] ; Yasuo Suzuki [Japon] | Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication |
| 001D18 |
Michel Bublot [France] | Les grippes aviaires, une menace permanente |
| 001D28 |
Ville T. Peltola [États-Unis] ; Jonathan A. Mccullers [États-Unis] | Respiratory viruses predisposing to bacterial infections: role of neuraminidase |
| 001D38 |
John C. Kash [États-Unis] ; Christopher F. Basler [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Victoria Carter [États-Unis] ; Rosalind Billharz [États-Unis] ; David E. Swayne [États-Unis] ; Ronald M. Przygodzki [États-Unis] ; Jeffery K. Taubenberger [États-Unis] ; Michael G. Katze [États-Unis] ; Terrence M. Tumpey [États-Unis] | Global host immune response: Pathogenesis and transcriptional profiling of type a influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus |
| 001D47 |
John Oxford [Royaume-Uni] ; Shobana Balasingam [Royaume-Uni] ; Rob Lambkin [Royaume-Uni] | A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community |
| 001D53 |
J. S. Oxford [Royaume-Uni] ; S. Bossuyt [Royaume-Uni] ; S. Balasingam [Royaume-Uni] ; A. Mann [Royaume-Uni] ; P. Novelli [Royaume-Uni] ; R. Lambkin [Royaume-Uni] | Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors |
| 001D79 |
R. Medeiros [France] ; N. Naffakh [France] ; J.-C. Manuguerra [France] ; S. Van Der Werf [France] | Structure et mécanismes de variation des virus grippaux |
| 001D88 |
S. Li [États-Unis] ; M. L. Perdue [États-Unis] ; E. Patzer [États-Unis] | Seed viruses containing novel avian HA and NA antigens for prevention against potential influenza pandemic |
| 001D90 |
Graeme Laver [Australie] ; Elspeth Garman [Royaume-Uni] | Pandemic influenza: its origin and control |
| 001E03 |
Maria C. Zambon [Royaume-Uni] | The pathogenesis of influenza in humans |
| 001E28 |
| «PLACE DES ANTICORPS ANTI-NEURAMINIDASE DANS LA PROTECTION CONTRE L'INFECTION GRIPPALE» |
| 001E34 |
M. C. Zambon [Royaume-Uni] | Epidemiology and pathogenesis of influenza |
| 001E36 |
M. Aymard [France] ; L. Gerentes ; N. Kessler ; C. Pilet ; G. Blancher ; J.-C. Sournia ; E. Aron ; C. Laverdant ; L. Le Minor | Place des anticorps antineuraminidase dans la protection contre la grippe. Discussion |
| 001E56 |
F. G. Hayden [États-Unis] | Antivirals for pandemic influenza |
